Cleared Traditional

K944226 - MSI PROCEDURE KIT

K944226 is an FDA 510(k) clearance for MSI PROCEDURE KIT, manufactured by Msi, Inc.. The device is a Class 2 Toxicology device with product code DOX cleared through the Traditional 510(k) pathway after a 295-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1995
Decision
295d
Days
Class 2
Risk

K944226 is an FDA 510(k) clearance for the MSI PROCEDURE KIT. Classified as Fluorometer, Lead (dedicated Instruments) (product code DOX), Class II - Special Controls.

Submitted by Msi, Inc. (Tarpon Springs, US). The FDA issued a Cleared decision on June 21, 1995 after a review of 295 days - an extended review cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3550 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.

View all Msi, Inc. devices

FDA 510(k) Submission Details - K944226

510(k) Number K944226 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 30, 1994
Decision Date June 21, 1995
Days to Decision 295 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
208d slower than avg
Panel avg: 87d · This submission: 295d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DOX Device Classification - Class 2, Special Controls

Product Code DOX Fluorometer, Lead (dedicated Instruments)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.